News & media
Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
New Employee Elected Directors to the Board of Zealand Pharma A/S
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
-
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
-
Zealand Pharma convenes its Annual General Meeting 2024
-
Zealand Pharma Announces Financial Results for the Full Year 2023
-
Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
-
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
-
Total number of shares and voting rights in Zealand Pharma at January 31, 2024
-
Zealand Pharma major shareholder announcement: Van Herk Investments
Corporate management
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer
-
David Kendall - Executive Vice President, Research & Development and Chief Medical Officer
-
Henriette Wennicke - Executive Vice President and Chief Financial Officer
-
Ivan Møller - Executive Vice President and Chief Operating Officer
-
Ravinder Chahil - Executive Vice President and General Counsel
Research and development
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
Logos and icons
-
)
Zealand Pharma Logo (RGB)
Stay up-to-date with the latest news from Zealand
Sign-up to receive press releases and company announcements directly to your inbox
Investor and Media contacts
